An exclusive report by The Wall Street Journal details how Microsoft unveiled OpenAI's unreleased GPT-4 to the world without ...

By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...

Hailed for his offensive talents, he quickly became the Rangers’ top prospect after the organization drafted him No. 23 ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...

The ice cream giant accused its parent company of removing its CEO because of his support for the brand’s activism.

Advocates for Putnam county farms, including a candidate for county Legislature, want Neal Tomann removed from agriculture ...

Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. The merger with Velodyne has expanded Ouster's customer base, improved ...